AI's Role in Psychedelic Therapy: Relational Competence Issues

AI's Integration in Psychedelic-Assisted Therapy

Artificial intelligence (AI) is increasingly being integrated into psychedelic-assisted therapy (PaT), primarily through facilitator training simulators and administrative tools used during therapy sessions. This trend highlights significant challenges in maintaining relational competence, which is crucial for therapeutic outcomes. The integration of AI in PaT is particularly notable given the emphasis on relational factors—such as therapeutic alliance and participant trust—as key determinants of success in psychedelic trials, as identified by a 2025 international Delphi consensus study.

Mechanisms and Context of AI Use

AI is being utilized in two main ways within PaT: as a simulation platform for training facilitators and as ambient AI tools for documentation during sessions, particularly in ketamine-assisted psychotherapy. These tools are designed to enhance the therapeutic environment by providing real-time feedback and support to facilitators. However, the altered states of consciousness induced by psychedelics present unique challenges to AI's relational competence framework, which includes components such as empathic presence, relational judgment, trustworthiness, transparency, accountable decision-making, and equity awareness.

Policy and Research Implications

The current lack of an accreditation infrastructure for AI tools in PaT raises significant policy questions. Unlike traditional medical education, which has established accreditation standards, AI platforms for facilitator competency are privately developed and lack formal oversight. This situation poses the risk of these platforms becoming de facto standards without adequate evaluation of their effectiveness and equity. The paper suggests that policymakers need to consider developing accreditation processes to ensure AI tools meet the necessary standards for relational competence in therapeutic settings.

Risks and Unknowns

While AI tools can enhance certain aspects of therapy, such as empathic presence and relational judgment, they also risk exacerbating existing inequities and accountability issues. The fragmented accountability infrastructure in PaT, coupled with its history of racial and cultural inequity, complicates the integration of AI. Trustworthiness and transparency of AI systems are particularly strained in the context of altered consciousness, where patients are more vulnerable. These challenges underscore the need for careful consideration of how AI tools are implemented and evaluated in psychedelic therapy.

Looking Forward

The future of AI in psychedelic therapy hinges on addressing these relational competence challenges and establishing robust policy frameworks. As AI continues to evolve, its role in PaT will likely expand, necessitating ongoing research and dialogue among stakeholders to ensure ethical and effective integration. Policymakers, researchers, and clinicians must collaborate to develop standards that prioritize patient safety and equity while harnessing the potential benefits of AI in therapeutic settings.